Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · IEX Real-Time Price · USD
3.610
0.00 (0.00%)
At close: May 17, 2024, 4:00 PM
3.530
-0.080 (-2.22%)
After-hours: May 17, 2024, 6:42 PM EDT
Elevation Oncology Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Elevation Oncology stock have an average target of 7.40, with a low estimate of 6.00 and a high estimate of 8.00. The average target predicts an increase of 104.99% from the current stock price of 3.61.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for ELEV stock from 5 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 2 | 2 | 2 | 3 | 3 | 4 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 1 | 1 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 4 | 3 | 4 | 4 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Stephens & Co. | Stephens & Co. | Buy Initiates $8 | Buy | Initiates | $8 | +121.61% | May 14, 2024 |
Wedbush | Wedbush | Buy Reiterates $8 | Buy | Reiterates | $8 | +121.61% | May 3, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $6 | Strong Buy | Reiterates | $6 | +66.20% | Apr 9, 2024 |
JMP Securities | JMP Securities | Buy Reiterates $7 | Buy | Reiterates | $7 | +93.91% | Mar 7, 2024 |
Wedbush | Wedbush | Buy Maintains $5 → $8 | Buy | Maintains | $5 → $8 | +121.61% | Mar 7, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.87
from -1.34
EPS Next Year
-0.90
from -0.87
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 30.7M | 53.2M |
Avg | n/a | n/a | n/a | 10.1M | 34.8M |
Low | n/a | n/a | n/a | n/a | 4.4M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 426.8% |
Avg | - | - | - | - | 244.3% |
Low | - | - | - | - | -56.9% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.79 | -0.65 | -0.53 | -0.63 | -0.33 |
Avg | -0.87 | -0.90 | -1.14 | -0.71 | -0.56 |
Low | -0.90 | -1.27 | -1.91 | -0.86 | -0.77 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.